Quantcast

Latest lung cancer Stories

2014-05-13 08:31:14

CVS Caremark signs on as national presenting sponsor to raise awareness of the #1 cancer killer of women CHICAGO, May 13, 2014 /PRNewswire/ -- Today, the American Lung Association, in partnership with national presenting sponsor, CVS Caremark, unveiled LUNG FORCE, a new initiative to make lung cancer in women a public health priority, drive policy change and increase research funding. To view the multimedia assets associated with this release, please click:...

2014-05-09 23:04:46

Markets Research Reports.biz added deep and professional market research reports on "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014" analysis and overview. (PRWEB) May 09, 2014 Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Small-Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer. It includes an overview of the trial numbers...

2014-05-09 19:06:35

Massachusetts Institute of Technology Nanoparticles that stagger delivery of 2 drugs knock out aggressive tumors in mice MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage. In studies with mice, the research team showed that this one-two punch, which relies on a nanoparticle that carries two drugs and releases them at different times, dramatically shrinks lung and breast...

2014-05-08 08:33:07

Clinicians detail how the Edge(TM) radiosurgery suite and other cancer treatment technologies from Varian Medical Systems are enabling fast, precise tumor targeting MINNEAPOLIS, May 8, 2014 /PRNewswire/ -- Radiation oncologists and a neurosurgeon from noted institutions in the U.S. and Europe report that they are able to use non-invasive radiosurgery to treat a widening variety of cancers due to technology advances that are making it possible to deliver these treatments more quickly...

2014-05-06 16:33:11

Hope Summit and New Scientific Grant Applications Kick Off Lung Cancer Hope Month WASHINGTON, May 6, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit, commemorates May, Lung Cancer Hope Month, as a time to celebrate the hope and promise of science in the ongoing quest for a world where no one dies from lung cancer. LUNGevity Foundation President and CEO Andrea Stern Ferris noted the remarkable progress in lung cancer treatments, growth of lung...

2014-05-05 20:25:53

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Molecular Diagnostics in Cancer Testinghttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_cancer_testing.htmlMolecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA...

2014-05-05 08:29:46

SAN DIEGO, May 5, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin(®) (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers. The open-label study is expected to enroll up to 64...

2014-05-02 16:24:22

Medicare Committee Decision Leaves Medicare-Reliant At Risk WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation President Andrea Ferris today commented on the Medicare panel decision against funding for CT scans. Ms. Ferris said, "LUNGevity Foundation is disappointed in the Medicare Evidence & Coverage Advisory Committee (MEDCAC) decision against covering annual CT scans to detect lung cancer in a high risk population. The results of the National Lung Cancer Screening...

2014-05-02 08:25:48

Ultrasound Imaging Platform Supports Better Detection and Characterization of Lesions in the Gastrointestinal Tract and Airways CENTER VALLEY, Pa., May 2, 2014 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today the launch of the next-generation EU-ME2 Ultrasound Processor, which can integrate endoscopic and endobronchial ultrasound...

2014-05-01 20:24:06

Ceritinib (brand name Zykadia(TM)) will be used for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib (brand name Xalkori(TM)) WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation applauds the FDA approval of Zykadia(TM) for the subset of anaplastic lymphoma kinase-positive (ALK+) patients with advanced cases of non-small cell lung cancer who have...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.